Disseminated coccidioidomycosis: a case report from the United kingdom.

Int J Clin Exp Pathol

Division of Pathology, School of Molecular Medical Sciences, University of Nottingham NG7 2UH, UK.

Published: January 2010

We reported the first case of disseminated coccidioidomycosis from the UK successfully treated with amphotericin B, where skin biopsy was the initial clue for the correct diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655149PMC

Publication Analysis

Top Keywords

disseminated coccidioidomycosis
8
coccidioidomycosis case
4
case report
4
report united
4
united kingdom
4
kingdom reported
4
reported case
4
case disseminated
4
coccidioidomycosis treated
4
treated amphotericin
4

Similar Publications

Article Synopsis
  • A 35-year-old male presented with back pain and masses on his arms, having a previous sacral lesion suspected to be a fungal infection that was never fully investigated.
  • CT and MRI showed destructive bone lesions indicating a possible disseminated infection, and biopsies confirmed the presence of Blastomyces dermatitidis.
  • Despite initial concerns about his condition, the patient had no neurological deficits and showed improvement with medical treatment, highlighting the importance of clinical evaluation in making surgical decisions for spinal fungal infections.
View Article and Find Full Text PDF

Updates in Coccidioidomycosis.

Infect Dis Clin North Am

December 2024

Department of Internal Medicine, Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, CA, USA; Department of Medical Microbiology and Immunology, University of California, Davis, CA, USA; UC-Davis Center for Valley Fever. Electronic address:

Coccidioidomycosis is the clinical disease caused by the dimorphic pathogenic fungi Coccidioides immitis and C posadasii. The number of clinically recognized coccidioidomycosis cases continues to increase yearly including in regions outside the traditional regions of endemicity. Following inhalation of Coccidioides spores, the course may range from asymptomatic exposure with resultant immunity, to a subacute pulmonary illness, to life-threatening disseminated infection.

View Article and Find Full Text PDF

Background: Coccidioidomycosis (Valley Fever) is a dimorphic fungal infection endemic to the southwest United States, Mexico, Central and South America, which can lead to chronic debilitating illness and death.

Objectives: This qualitative study was conducted to develop a bespoke patient-reported outcome measure for patients with chronic disseminated coccidioidomycosis to assess health-related quality of life (HRQoL) impacts.

Patients And Methods: Online, first-person narratives of patient experiences of disseminated coccidioidomycosis were used to create a patient-centred conceptual model of symptoms and impacts of the condition.

View Article and Find Full Text PDF

How I Do It: Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes.

Chest

December 2024

Division of Infectious Diseases, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA; University of Arizona, Tucson, AZ, USA.

Coccidioidomycosis (CM), caused by the dimorphic fungi Coccidioides immitis (C. immitis) and C. posadasii, is recognized as an increasing threat both nationally and worldwide.

View Article and Find Full Text PDF
Article Synopsis
  • Coccidioidomycosis is a serious fungal infection that can be transmitted through organ transplantation, with a review of cases from 2013 to 2022 revealing significant risks.
  • Seven deceased donors transmitted the infection to eight recipients, resulting in a 40% infection rate among organ recipients.
  • The study highlights the importance of thorough donor evaluations and antifungal treatment to reduce the high mortality associated with these infections post-transplant.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!